{"id":4292,"date":"2020-12-30T20:33:49","date_gmt":"2020-12-31T01:33:49","guid":{"rendered":"http:\/\/groupedevonian.com\/?p=4292"},"modified":"2024-01-05T10:07:34","modified_gmt":"2024-01-05T15:07:34","slug":"groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions","status":"publish","type":"post","link":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/","title":{"rendered":"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions"},"content":{"rendered":"<p style=\"text-align: center;\">COMMUNIQU\u00c9 DE PRESSE<br \/>\n<em>Pour publication imm\u00e9diate<\/em><\/p>\n<p>&nbsp;<\/p>\n<h1>Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions.<\/h1>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><em><strong>Le pr\u00e9sent communiqu\u00e9 ne doit pas \u00eatre distribu\u00e9 aux agences de diffusion de communiqu\u00e9s de presse des \u00c9tats-Unis ni diffus\u00e9 aux \u00c9tats-Unis<\/strong><\/em><\/p>\n<p><strong>QU\u00c9BEC, le 30 D\u00e9cembre, 2020<\/strong> \u2013 Groupe Sant\u00e9 Devonian inc (\u00ab <strong>Devonian<\/strong> \u00bb ou la \u00ab <strong>Soci\u00e9t\u00e9<\/strong> \u00bb) (<strong>TSXv: GSD<\/strong>), une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement ax\u00e9e sur l\u2019\u00e9laboration d\u2019un portefeuille unique de m\u00e9dicaments d\u2019ordonnance et de produits cosm\u00e9ceutiques d\u2019origine botanique, annonce la cl\u00f4ture d&rsquo;un placement priv\u00e9 (le\u00a0\u00ab\u00a0<strong>Placement\u00a0<\/strong>\u00bb) par l\u2019\u00e9mission de 10 100 000 unit\u00e9s (les \u00ab <strong>Unit\u00e9s<\/strong> \u00bb) au prix de 0,12 $ l\u2019Unit\u00e9 pour un produit brut total de 1 212 000 $. Chaque Unit\u00e9 est compos\u00e9e d\u2019une action \u00e0 droit de vote subalterne et d\u2019un-demi (1\/2) bon de souscription d\u2019action (chaque bon de souscription d\u2019action entier, un \u00ab <strong>Bon de souscription<\/strong> \u00bb). Chaque Bon entier de souscription conf\u00e8rera \u00e0 son porteur le droit d\u2019acqu\u00e9rir une action \u00e0 droit de vote subalterne \u00e0 un prix de 0,15 $ jusqu\u2019au 29\u00a0d\u00e9cembre\u00a02022.<br \/>\nLa Soci\u00e9t\u00e9 a pay\u00e9 des frais d\u2019interm\u00e9diation \u00e0 Raymond James Ltd. pour un montant en esp\u00e8ces de 22 100 $.<\/p>\n<p>Le produit du Placement sera utilis\u00e9 \u00e0 des fins g\u00e9n\u00e9rales de fonds de roulement.<\/p>\n<p>Tous les titres \u00e9mis dans le cadre du Placement sont assujettis \u00e0 une p\u00e9riode de restriction en mati\u00e8re de revente pr\u00e9vue par la l\u00e9gislation en valeurs mobili\u00e8res d\u2019une dur\u00e9e de quatre mois et un jour, se terminant le 30 avril 2021. Ce Placement a re\u00e7u l\u2019approbation conditionnelle de la Bourse de Croissance TSX et demeure soumis \u00e0 l\u2019approbation finale de la Bourse de croissance TSX.<\/p>\n<p>Ce communiqu\u00e9 ne constitue ni une offre de vente ni la sollicitation d\u2019une offre d\u2019achat visant des titres aux \u00c9tats-Unis. Les titres n\u2019ont pas \u00e9t\u00e9 ni ne seront inscrits en vertu de la loi des \u00c9tats-Unis intitul\u00e9e Securities Act of 1933, dans sa version modifi\u00e9e (la \u00ab Loi des \u00c9tats-Unis \u00bb) ou de toute autre loi \u00e9tatique, et ne peuvent \u00eatre offerts ou vendus aux \u00c9tats-Unis ou \u00e0 une personne am\u00e9ricaine, ou pour le compte ou le b\u00e9n\u00e9fice d\u2019une personne am\u00e9ricaine, sans enregistrement pr\u00e9alable en vertu de la Loi des \u00c9tats-Unis et autres lois \u00e9tatiques sur les valeurs mobili\u00e8res applicables ou en l\u2019absence d\u2019une dispense d\u2019inscription applicable.<\/p>\n<p><strong>Octroi d\u2019options d\u2019achat d\u2019actions<\/strong><\/p>\n<p>De plus, la Soci\u00e9t\u00e9 annonce que le conseil d\u2019administration a approuv\u00e9 l\u2019octroi d\u2019options d\u2019achat d\u2019actions pour acheter des actions \u00e0 droit de vote subalterne dans le capital social de la Soci\u00e9t\u00e9 (les \u00ab Options \u00bb). Ces Options sont exer\u00e7ables au prix de 0,12 $ pour une p\u00e9riode de dix ans \u00e0 compter de la date d\u2019attribution. La Soci\u00e9t\u00e9 a accord\u00e9 801,645 Options \u00e0 la direction de la Soci\u00e9t\u00e9. Les Options sont exer\u00e7ables \u00e0 la date d\u2019attribution.<\/p>\n<p><strong>\u00c0 propos de Devonian<br \/>\n<\/strong>Groupe Sant\u00e9 Devonian inc. est une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement qui emploie une strat\u00e9gie novatrice ciblant des besoins m\u00e9dicaux non combl\u00e9s. La principale strat\u00e9gie de Devonian est de d\u00e9velopper des m\u00e9dicaments d\u2019ordonnance d\u2019origine botanique d\u00e9riv\u00e9s d\u2019\u00e9l\u00e9ment v\u00e9g\u00e9tal et d\u2019algue pour le traitement des maladies inflammatoires auto-immunes incluant, mais sans s\u2019y limiter, la colite ulc\u00e9reuse et la dermatite atopique. Fond\u00e9 sur une assise de 15 ann\u00e9es de recherche, l\u2019objectif de Devonian est \u00e9galement appuy\u00e9 par les directives r\u00e9glementaires de la FDA, l\u2019agence am\u00e9ricaine des produits alimentaires et m\u00e9dicamenteux, favorisant un processus de d\u00e9veloppement de produits m\u00e9dicamenteux botaniques d\u2019ordonnance plus efficient que celui des m\u00e9dicaments d\u2019ordonnance classique. La Soci\u00e9t\u00e9 est \u00e9galement engag\u00e9e dans le d\u00e9veloppement de produits cosm\u00e9ceutiques de grande valeur, mettant \u00e0 profit la m\u00eame approche de propri\u00e9t\u00e9 utilis\u00e9e avec ses offres pharmaceutiques. Incorpor\u00e9e en 2015, Groupe Sant\u00e9 Devonian inc. a son si\u00e8ge social \u00e0 Qu\u00e9bec, Canada o\u00f9 sont \u00e9galement situ\u00e9es ses installations d\u2019extraction de pointe avec tra\u00e7abilit\u00e9 compl\u00e8te \u00ab\u2009de la semence au comprim\u00e9\u2009\u00bb. Sa r\u00e9cente acquisition de la division commerciale Altius Healthcare multiplie ses occasions de diversification et de croissance. Devonian est une soci\u00e9t\u00e9 cot\u00e9e \u00e0 la Bourse de croissance TSX de Toronto (<strong>TSXv:GSD<\/strong>).<\/p>\n<p>Pour plus de d\u00e9tails, visitez le <a href=\"https:\/\/groupedevonian.com\/fr\/\">www.groupedevonian.com<\/a><\/p>\n<p><strong>\u00c9nonc\u00e9s prospectifs<br \/>\n<\/strong>Le pr\u00e9sent communiqu\u00e9 renferme des \u00e9nonc\u00e9s prospectifs sur les objectifs, les strat\u00e9gies et les activit\u00e9s de Devonian. Ces \u00e9nonc\u00e9s prospectifs sont assujettis \u00e0 certains risques et incertitudes. Ces \u00e9nonc\u00e9s sont de nature \u00ab prospective \u00bb puisqu\u2019ils sont fond\u00e9s sur nos attentes pr\u00e9sentes \u00e0 l\u2019\u00e9gard des march\u00e9s dans lesquels nous exer\u00e7ons nos activit\u00e9s et sur diverses estimations et hypoth\u00e8ses. Les \u00e9v\u00e9nements ou les r\u00e9sultats r\u00e9els sont susceptibles de diff\u00e9rer consid\u00e9rablement de ceux pr\u00e9vus dans le cadre des \u00e9nonc\u00e9s prospectifs si des risques connus ou inconnus affectent nos activit\u00e9s ou si nos estimations ou nos hypoth\u00e8ses s\u2019av\u00e8rent inexactes. Ces risques, estimations et hypoth\u00e8ses incluent, mais sans s\u2019y limiter, l\u2019utilisation pr\u00e9vue du produit du Placement, l\u2019approbation finale de la Bourse de croissance TSX en lien avec le Placement, le paragraphe \u00ab\u00a0\u00c0 propos de Devonian\u00a0\u00bb ci-dessus, la capacit\u00e9 de Devonian d\u2019assurer le d\u00e9veloppement, la fabrication et la commercialisation de produits pharmaceutiques et cosm\u00e9 ceutiques \u00e0 valeur ajout\u00e9e, la disponibilit\u00e9 de ressources financi\u00e8res pour mener \u00e0 bien des projets de recherche et d\u00e9veloppement, le succ\u00e8s et la dur\u00e9e d\u2019\u00e9tudes cliniques, la capacit\u00e9 de Devonian de se pr\u00e9valoir des occasions d\u2019affaires dans l\u2019industrie pharmaceutique et cosm\u00e9ceutique, les incertitudes li\u00e9es au processus de r\u00e9glementation et tout changement du contexte \u00e9conomique. Vous trouverez une analyse plus exhaustive des risques qui pourraient faire en sorte que les \u00e9v\u00e9nements ou r\u00e9sultats r\u00e9els diff\u00e8rent de nos attentes pr\u00e9sentes de fa\u00e7on importante dans le prospectus en date du 21 avril 2017, sous la rubrique \u00ab Facteurs de risque \u00bb. Par cons\u00e9quent, nous ne pouvons garantir la r\u00e9alisation des \u00e9nonc\u00e9s prospectifs. Par ailleurs, nous ne nous engageons aucunement \u00e0 mettre \u00e0 jour ces \u00e9nonc\u00e9s prospectifs, m\u00eame si de nouveaux renseignements devenaient disponibles, \u00e0 la suite d\u2019\u00e9v\u00e9nements futurs ou pour toute autre raison, \u00e0 moins d\u2019y \u00eatre tenus en vertu des lois et r\u00e8glements applicables aux valeurs mobili\u00e8res.<\/p>\n<p><em>La Bourse de croissance TSX et son fournisseur de services de r\u00e9glementation (au sens attribu\u00e9 \u00e0 ce terme dans les politiques de la Bourse de croissance TSX) n\u2019assument aucune responsabilit\u00e9 quant \u00e0 la pertinence ou \u00e0 l\u2019exactitude du pr\u00e9sent communiqu\u00e9.<\/em><\/p>\n<p><strong>Contact\u00a0:<\/strong><\/p>\n<p>Dr Andr\u00e9 P. Boulet, PhD<br \/>\nPr\u00e9sident-directeur g\u00e9n\u00e9ral<br \/>\nGroupe Sant\u00e9 Devonian inc.<br \/>\nT\u00e9l\u00e9phone : (514) 248-7509<br \/>\nCourriel : <a href=\"mailto:apboulet@groupedevonian.com\" target=\"_blank\" rel=\"noopener noreferrer\">apboulet@groupedevonian.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>COMMUNIQU\u00c9 DE PRESSE Pour publication imm\u00e9diate &nbsp; Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions. &nbsp; Le pr\u00e9sent communiqu\u00e9 ne doit pas \u00eatre distribu\u00e9 aux agences de diffusion de communiqu\u00e9s de presse des \u00c9tats-Unis ni diffus\u00e9 aux \u00c9tats-Unis QU\u00c9BEC, le 30 D\u00e9cembre, 2020 \u2013 Groupe Sant\u00e9 Devonian inc (\u00ab [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[47,35],"tags":[],"class_list":["post-4292","post","type-post","status-publish","format-standard","hentry","category-2020-fr","category-communiques-de-presse"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions - DEVONIAN HEALTH GROUP INC.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions - DEVONIAN HEALTH GROUP INC.\" \/>\n<meta property=\"og:description\" content=\"COMMUNIQU\u00c9 DE PRESSE Pour publication imm\u00e9diate &nbsp; Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions. &nbsp; Le pr\u00e9sent communiqu\u00e9 ne doit pas \u00eatre distribu\u00e9 aux agences de diffusion de communiqu\u00e9s de presse des \u00c9tats-Unis ni diffus\u00e9 aux \u00c9tats-Unis QU\u00c9BEC, le 30 D\u00e9cembre, 2020 \u2013 Groupe Sant\u00e9 Devonian inc (\u00ab [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/\" \/>\n<meta property=\"og:site_name\" content=\"DEVONIAN HEALTH GROUP INC.\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-31T01:33:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-05T15:07:34+00:00\" \/>\n<meta name=\"author\" content=\"acxdev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"acxdev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\\\/\"},\"author\":{\"name\":\"acxdev\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/person\\\/ff9b4cc2d46ac4fb34e4f4641825f159\"},\"headline\":\"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions\",\"datePublished\":\"2020-12-31T01:33:49+00:00\",\"dateModified\":\"2024-01-05T15:07:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\\\/\"},\"wordCount\":1192,\"publisher\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\"},\"articleSection\":[\"2020\",\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\\\/\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\\\/\",\"name\":\"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions - DEVONIAN HEALTH GROUP INC.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-12-31T01:33:49+00:00\",\"dateModified\":\"2024-01-05T15:07:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\",\"name\":\"DEVONIAN HEALTH GROUP INC.\",\"description\":\"Botanical pharmaceutical corporation\",\"publisher\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\",\"name\":\"Groupe Sant\u00e9 Devonian inc.\",\"alternateName\":\"Groupe Sant\u00e9 Devonian inc.\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-devonian-2x.png\",\"contentUrl\":\"https:\\\/\\\/groupedevonian.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-devonian-2x.png\",\"width\":309,\"height\":183,\"caption\":\"Groupe Sant\u00e9 Devonian inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/person\\\/ff9b4cc2d46ac4fb34e4f4641825f159\",\"name\":\"acxdev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"caption\":\"acxdev\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions - DEVONIAN HEALTH GROUP INC.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/","og_locale":"fr_FR","og_type":"article","og_title":"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions - DEVONIAN HEALTH GROUP INC.","og_description":"COMMUNIQU\u00c9 DE PRESSE Pour publication imm\u00e9diate &nbsp; Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions. &nbsp; Le pr\u00e9sent communiqu\u00e9 ne doit pas \u00eatre distribu\u00e9 aux agences de diffusion de communiqu\u00e9s de presse des \u00c9tats-Unis ni diffus\u00e9 aux \u00c9tats-Unis QU\u00c9BEC, le 30 D\u00e9cembre, 2020 \u2013 Groupe Sant\u00e9 Devonian inc (\u00ab [&hellip;]","og_url":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/","og_site_name":"DEVONIAN HEALTH GROUP INC.","article_published_time":"2020-12-31T01:33:49+00:00","article_modified_time":"2024-01-05T15:07:34+00:00","author":"acxdev","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"acxdev","Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/#article","isPartOf":{"@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/"},"author":{"name":"acxdev","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/person\/ff9b4cc2d46ac4fb34e4f4641825f159"},"headline":"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions","datePublished":"2020-12-31T01:33:49+00:00","dateModified":"2024-01-05T15:07:34+00:00","mainEntityOfPage":{"@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/"},"wordCount":1192,"publisher":{"@id":"https:\/\/groupedevonian.com\/fr\/#organization"},"articleSection":["2020","Communiqu\u00e9s de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/","url":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/","name":"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions - DEVONIAN HEALTH GROUP INC.","isPartOf":{"@id":"https:\/\/groupedevonian.com\/fr\/#website"},"datePublished":"2020-12-31T01:33:49+00:00","dateModified":"2024-01-05T15:07:34+00:00","breadcrumb":{"@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/groupedevonian.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Groupe Sant\u00e9 Devonian annonce la cl\u00f4ture d\u2019un placement priv\u00e9 et l\u2019octroi d\u2019options d\u2019achat d\u2019actions"}]},{"@type":"WebSite","@id":"https:\/\/groupedevonian.com\/fr\/#website","url":"https:\/\/groupedevonian.com\/fr\/","name":"DEVONIAN HEALTH GROUP INC.","description":"Botanical pharmaceutical corporation","publisher":{"@id":"https:\/\/groupedevonian.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/groupedevonian.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/groupedevonian.com\/fr\/#organization","name":"Groupe Sant\u00e9 Devonian inc.","alternateName":"Groupe Sant\u00e9 Devonian inc.","url":"https:\/\/groupedevonian.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/groupedevonian.com\/wp-content\/uploads\/2022\/05\/logo-devonian-2x.png","contentUrl":"https:\/\/groupedevonian.com\/wp-content\/uploads\/2022\/05\/logo-devonian-2x.png","width":309,"height":183,"caption":"Groupe Sant\u00e9 Devonian inc."},"image":{"@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/person\/ff9b4cc2d46ac4fb34e4f4641825f159","name":"acxdev","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","caption":"acxdev"}}]}},"_links":{"self":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/4292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/comments?post=4292"}],"version-history":[{"count":3,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/4292\/revisions"}],"predecessor-version":[{"id":4301,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/4292\/revisions\/4301"}],"wp:attachment":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/media?parent=4292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/categories?post=4292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/tags?post=4292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}